97色偷偷色噜噜狠狠爱网站-男女啪啪做爰高潮无遮挡-欧美精品一区二区三区在线-永久免费的av在线电影网无码-级r片内射在线视频播放

Home>About Livzon>Company Profile

Profile of Zhuhai Livzon Diagnostics Inc.
Zhuhai Livzon Diagnostics Inc. (hereinafter referred to as “Livzon Diagnostics”) was established in 1989. It is the first high-tech subsidiary of the listed company, Livzon Pharmaceutical Group (A-share and H-share listed company), who specializing in in-vitro diagnostics in research, developing, manufacturing and marketing of diagnosis products and automation equipment. Livzon Diagnostics is one of the earliest in vitro diagnostic products manufacturing enterprises in China, a national high-tech enterprise.

Livzon Diagnostics has established many technical platforms such as Enzyme-linked Immunoassay, lateral flow chromatography, Microorganisms testing, Molecular testing, Multiple-detection Immunoassay, Single-test Chemiluminescence immunoassay, Mast Cell Degranulation Test for Allergy, etc. Meanwhile, Livzon Diagnostics also has fully automatic equipment development capability. The products cover many disease areas such as infectious diseases, respiratory infection, tumor marker detection, drug concentration monitoring, autoimmunity, allergen detection, and blood safety. Therefore, Livzon Diagnostics has high market share in respiratory infections, infectious diseases, and drug concentration monitoring with market share as high as 50% -90%.

Zhuhai Livzon Diagnostics Inc.  has equipped with its industrialization base for Research and Development, Production and Office use, which covers an area of more than 23,000 square meters, construction area of more than 44,000 square meters, including 6000 square meters for Research and Development, which attracts professional elite talents from Laboratory Science, Biological engineering and many other fields. Zhuhai Livzon Diagnostics Inc. owns 5 Research and Development teams spread in 3 Research and Development centers, which located in Zhuhai, Shanghai and Suzhou city. The total Research and Development personnel accounted for nearly 20% , meanwhile the annual Research and Development investment reaches more than 10% of Sales Revenue. Beside its independent Research and Development, Zhuhai Livzon Diagnostics Inc. has established long-term successful cooperation with many first-class International Biomedical Enterprises such as Fujirebro from Japan, Siemens in Germany, and MP company (USA), which has enhanced its comprehensive service capabilities. Zhuhai Livzon Diagnostics Inc. has won the title of honor as "National High-tech Enterprises", "In vitro diagnostic Engineering Technology Research Center of Guangdong Province ", "Guangdong Provincial Enterprise Technology Center", "Innovative Enterprises of Guangdong Province " and the national "Post-doctoral Research Station". With a complete quality management system in production, Zhuhai Livzon Diagnostics Inc. has well achieved the national GMP certification, GSP certification and ISO13485/ISO9001 certification.
Livzon Overview
3
R&D centers
5
R&D teams
20%
scientific research personnel
50%
personnel with master degree
6000
R&D land area (m2)
作為中國IVD行業的先行者,麗珠試劑服務產品涵蓋了傳染性疾病、呼吸道感染、腫瘤標志物檢測、藥物濃度監測、自身免疫、過敏原檢測及血液安全等眾多領域,在呼吸道感染、傳染性疾病、藥物濃度監測等領域的市場占有率處于國內領先地位,多項產品市場占有率高達50%-90%。在2019年底中國爆發新型冠狀病毒的第一時間,麗珠試劑便投入研發,迅速研制出新型冠狀病毒(2019-nCoV)IgM / IgG抗體檢測試劑盒(膠體金法)產品,并獲證上市,助力國內外疫情防控。
  • 5.jpg

  • 6.jpg

Livzon Diagnostics Technology Theme Exhibition Hall
Focus on disease research · Create new detection technology

主站蜘蛛池模板: 色综合久久久久无码专区| 色yeye香蕉凹凸视频在线观看| 成人性生交大片免费看小说| 狠狠色噜噜狠狠狠狠888奇禾| 国产成人精品无码一区二区三区| 久久久国产打桩机| 西西人体大胆午夜视频| 国产免费丝袜调教视频| 中文字幕日韩精品无码内射| 国产精品国产亚洲区艳妇糸列短篇 | 狠狠cao日日橹夜夜十橹| 国产精品久久久久久久久| 中文字幕奈奈美被公侵犯| 日韩国产成人无码av毛片| 韩国三级中文字幕hd久久精品| 无码人妻精品一区二区在线视频 | 人与禽交av在线播放| 精品黑人一区二区三区久久| 婷婷色中文字幕综合在线| 国产精品久久久久久久久久久久午夜片| 国产第一页屁屁影院| 亚洲成a人片在线观看久| 久久综合给合久久狠狠97色| 久久国产劲暴∨内射| 国产情侣疯狂作爱系列| 亚洲成av人片在线观看ww| 寂寞少妇做spa按摩无码| 好吊视频一区二区三区| 久久精品国产网红主播| 996久久国产精品线观看| 一线二线三线天堂| 一本久久综合亚洲鲁鲁五月天| 免费久久99精品国产自在现线| 国内精品伊人久久久久影院麻豆| 国产性猛交╳xxx乱大交| 国产精品久久国产精品99| 国产丝袜美女一区二区三区| 妺妺窝人体色www在线下载| 日本精品人妻无码77777| 国产精品免费看久久久| 中文字幕人成无码人妻综合社区 |